LI-RADS ancillary features on contrast-enhanced ultrasonography.
Contrast-enhanced ultrasound
Hepatocellular carcinoma
Ultrasonography
Journal
Ultrasonography (Seoul, Korea)
ISSN: 2288-5919
Titre abrégé: Ultrasonography
Pays: Korea (South)
ID NLM: 101626019
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
01
10
2019
accepted:
09
05
2020
pubmed:
2
6
2020
medline:
2
6
2020
entrez:
1
6
2020
Statut:
ppublish
Résumé
The Liver Imaging Reporting and Data System (LI-RADS) was created to standardize liver imaging in patients at high risk for hepatocellular carcinoma (HCC), and it uses a diagnostic algorithm to assign categories that reflect the relative probability of HCC, non-HCC malignancies, or benign focal liver lesions. In addition to major imaging features, ancillary features (AFs) are used by radiologists to refine the categorization of liver nodules. In the present document, we discuss and explain the application of AFs currently defined within the LI-RADS guidelines. We also explore possible additional AFs visible on contrast-enhanced ultrasonography (CEUS). Finally, we summarize the management of CEUS LI-RADS features, including the role of current and potential future AFs.
Identifiants
pubmed: 32475089
pii: usg.19052
doi: 10.14366/usg.19052
pmc: PMC7315297
doi:
Types de publication
Journal Article
Langues
eng
Pagination
221-228Références
Ultraschall Med. 1999 Feb;20(1):9-14
pubmed: 10226340
Radiology. 2018 Jan;286(1):29-48
pubmed: 29166245
Hepatology. 2007 May;45(5):1139-45
pubmed: 17464990
World J Gastroenterol. 2015 Jul 28;21(28):8541-61
pubmed: 26229397
N Engl J Med. 2019 Apr 11;380(15):1450-1462
pubmed: 30970190
Z Gastroenterol. 2015 Nov;53(11):1267-75
pubmed: 26562401
Abdom Radiol (NY). 2018 Jan;43(1):127-142
pubmed: 28819825
Endosc Ultrasound. 2016 Nov-Dec;5(6):355-362
pubmed: 27824024
Radiographics. 2017 Nov-Dec;37(7):1994-2017
pubmed: 29131761
AJR Am J Roentgenol. 1993 Jun;160(6):1177-87
pubmed: 8388618
Liver Int. 2007 Aug;27(6):748-57
pubmed: 17617117
Ultraschall Med. 2020 Feb 26;:
pubmed: 32102105
Semin Roentgenol. 2016 Oct;51(4):301-307
pubmed: 27743566
Ultrasound Med Biol. 2020 May;46(5):1216-1223
pubmed: 32115307
J Comput Assist Tomogr. 1996 May-Jun;20(3):337-42
pubmed: 8626886
Ultrasound Int Open. 2018 Jan;4(1):E2-E15
pubmed: 29423461
Radiology. 2020 Apr;295(1):245-247
pubmed: 32068508
Ultraschall Med. 2012 Aug;33(4):344-51
pubmed: 22843433
Oncotarget. 2017 Apr 19;8(31):51224-51237
pubmed: 28881643
Ultraschall Med. 2017 Jun;38(3):320-324
pubmed: 28329875
Abdom Radiol (NY). 2018 Jan;43(1):82-100
pubmed: 28647768
Abdom Radiol (NY). 2017 Aug;42(8):2089-2100
pubmed: 28352950
Br J Radiol. 2005 Aug;78(932):704-7
pubmed: 16046421
Clin Mol Hepatol. 2017 Dec;23(4):280-289
pubmed: 28911220
J Ultrasound Med. 2020 Feb 20;:
pubmed: 32078173
Z Gastroenterol. 2005 Mar;43(3):289-94
pubmed: 15765302
Radiographics. 2019 May-Jun;39(3):690-708
pubmed: 31059393
Ultrasound Med Biol. 2019 Jan;45(1):1-10
pubmed: 30396597
Abdom Radiol (NY). 2018 Jan;43(1):158-168
pubmed: 29209739
Abdom Radiol (NY). 2018 Apr;43(4):861-879
pubmed: 29151131
Korean J Hepatol. 2010 Dec;16(4):414-7
pubmed: 21415588
Infect Agent Cancer. 2017 Apr 28;12:23
pubmed: 28465718
Ultraschall Med. 2017 Jan;38(1):85-86
pubmed: 28249328
Radiology. 2015 Jun;275(3):698-707
pubmed: 25658038